# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-019750
Filing Date
2025-10-27
Accepted
2025-10-27 16:30:06
Documents
3
Period of Report
2025-10-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm | DEF 14A | 314969
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 408990
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 328204
| Complete submission text file | 0001493152-25-019750.txt |  | 1331684

Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38286 | Film No.: 251420228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)